106 related articles for article (PubMed ID: 16835348)
1. Lack of associations among cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a nested case-control study of lung cancer within the physicians' health study.
Perera FP; Tang D; Brandt-Rauf P; Santella RM; Mooney LV; Tu YH; Bendkowska I; Bell DA
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1417-9. PubMed ID: 16835348
[No Abstract] [Full Text] [Related]
2. Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.
Khlifi R; Messaoud O; Rebai A; Hamza-Chaffai A
Biomed Res Int; 2013; 2013():582768. PubMed ID: 24151610
[TBL] [Abstract][Full Text] [Related]
3. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
4. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1, cigarette smoking, and colon and rectal cancer.
Slattery ML; Samowtiz W; Ma K; Murtaugh M; Sweeney C; Levin TR; Neuhausen S
Am J Epidemiol; 2004 Nov; 160(9):842-52. PubMed ID: 15496536
[TBL] [Abstract][Full Text] [Related]
7. Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.
Khlifi R; Ben Salah G; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014 Sep; 41(9):5735-43. PubMed ID: 24934312
[TBL] [Abstract][Full Text] [Related]
8. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
10. Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues.
Kim SJ; Kang HS; Jung SY; Min SY; Lee S; Kim SW; Kwon Y; Lee KS; Shin KH; Ro J
J Mol Med (Berl); 2010 Nov; 88(11):1123-31. PubMed ID: 20628863
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
[TBL] [Abstract][Full Text] [Related]
12. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
13. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay.
Labuda D; Krajinovic M; Richer C; Skoll A; Sinnett H; Yotova V; Sinnett D
Anal Biochem; 1999 Nov; 275(1):84-92. PubMed ID: 10542112
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
16. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
17. CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Huang FM; Chen HC; Khan MA; Yang FL; Wan XX; Xu AH; Ou-yang FD; Zhang DZ
Med Oncol; 2013 Jun; 30(2):521. PubMed ID: 23471717
[TBL] [Abstract][Full Text] [Related]
18. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
19. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.
Li D; Firozi PF; Zhang W; Shen J; DiGiovanni J; Lau S; Evans D; Friess H; Hassan M; Abbruzzese JL
Mutat Res; 2002 Jan; 513(1-2):37-48. PubMed ID: 11719088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
